L01EX Other protein kinase inhibitors
ATC class of level 4 – chemical subgroup
This page lists the patient medication information or the product monograph for 30 drugs in this drug class and its subclasses.
- 30 prescription (Rx)
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,069 drugs
- L01 Antineoplastic agents 616 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
-
L01EX Other protein kinase inhibitors 30 drugs
- L01EX01 Sunitinib 5 drugs
- L01EX02 Sorafenib 2 drugs
- L01EX03 Pazopanib 5 drugs
- L01EX05 Regorafenib 1 drug
- L01EX07 Cabozantinib 1 drug
- L01EX08 Lenvatinib 1 drug
- L01EX09 Nintedanib 5 drugs
- L01EX10 Midostaurin 1 drug
- L01EX11 Quizartinib 1 drug
- L01EX12 Larotrectinib 1 drug
- L01EX14 Entrectinib 1 drug
- L01EX18 Avapritinib 1 drug
- L01EX19 Ripretinib 1 drug
- L01EX22 Selpercatinib 1 drug
- L01EX23 Pralsetinib 1 drug
- L01EX27 Capivasertib 1 drug
- L01EX28 Repotrectinib 1 drug
-
L01EX Other protein kinase inhibitors 30 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
- L01 Antineoplastic agents 616 drugs
Active ingredients of the class
- Avapritinib 1 drug
- Cabozantinib (cabozantinib malate) 1 drug
- Capivasertib 1 drug
- Entrectinib 1 drug
- Larotrectinib (larotrectinib sulfate) 1 drug
- Lenvatinib (lenvatinib mesylate) 1 drug
- Midostaurin 1 drug
- Nintedanib (nintedanib esilate) 5 drugs
- Pazopanib (pazopanib hydrochloride) 5 drugs
- Pralsetinib 1 drug
- Quizartinib (quizartinib hydrochloride) 1 drug
- Regorafenib 1 drug
- Repotrectinib 1 drug
- Ripretinib 1 drug
- Selpercatinib 1 drug
- Sorafenib (sorafenib tosylate) 2 drugs
- Sunitinib (sunitinib malate) 5 drugs
Drugs in the class and its subclasses
Other classes of the same level
- L01EA BCR-ABL tyrosine kinase inhibitors 30 drugs
- L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors 16 drugs
- L01EC B-Raf serine-threonine kinase (BRAF) inhibitors 3 drugs
- L01ED Anaplastic lymphoma kinase (ALK) inhibitors 4 drugs
- L01EE Mitogen-activated protein kinase (MEK) inhibitors 5 drugs
- L01EF Cyclin-dependent kinase (CDK) inhibitors 7 drugs
- L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors 1 drug
- L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors 5 drugs
- L01EJ Janus-associated kinase (JAK) inhibitors 3 drugs
- L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors 3 drugs
- L01EL Bruton's tyrosine kinase (BTK) inhibitors 4 drugs
- L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors 3 drugs
Other names of the drug class
- English (United Kingdom): L01EX Other protein kinase inhibitors
- German: L01EX Andere Proteinkinase-Inhibitoren
- German (Austria): L01EX Andere Proteinkinase-Inhibitoren
- Italian: L01EX Altri inbitori della proteina chinasi
- Turkish: L01EX ATC'deki diğer protein kinaz inhibitörleri
- Czech: L01EX Jiné inhibitory proteinkináz
- Slovak: L01EX Iné inhibítory proteínkinázy
- German (Switzerland): L01EX Andere Proteinkinase-Inhibitoren
- Italian (Switzerland): L01EX Altri inbitori della proteina chinasi
- Dutch: L01EX Overige proteïnekinaseremmers
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L01EX
Ask your doctor or pharmacist for advice.